BBIO
BridgeBio Pharma, Inc.- Last price
- $68.42
- As of
Active signals for BBIO
No recent signals on BBIO in the last 180 days.
Top institutional holders of BBIO (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | $1.1B | 2.92% | -9.9% |
| VIKING GLOBAL INVESTORS LP | $879.4M | 2.46% | -17.7% |
| VIKING GLOBAL INVESTORS LP | $829.9M | 2.16% | , |
| TWO SIGMA INVESTMENTS, LP | $231.7M | 0.19% | +60.3% |
| D. E. Shaw & Co., Inc. | $189M | 0.11% | +15.0% |
| D. E. Shaw & Co., Inc. | $169.4M | 0.09% | +1213.3% |
| TWO SIGMA INVESTMENTS, LP | $148.9M | 0.21% | -16.4% |
| TWO SIGMA INVESTMENTS, LP | $121M | 0.18% | , |
| D. E. Shaw & Co., Inc. | $106.5M | 0.06% | , |
| CITADEL ADVISORS LLC | $84M | 0.01% | +53.4% |
| CITADEL ADVISORS LLC | $40.7M | 0.01% | , |
| D. E. Shaw & Co., Inc. | $28.4M | 0.02% | , |
| RENAISSANCE TECHNOLOGIES LLC | $27.2M | 0.04% | , |
| Bridgewater Associates, LP | $19.3M | 0.09% | +501.0% |
| RENAISSANCE TECHNOLOGIES LLC | $16.7M | 0.02% | , |
| D. E. Shaw & Co., Inc. | $8.8M | 0.00% | , |
| CITADEL ADVISORS LLC | $8.5M | 0.00% | -12.7% |
| CITADEL ADVISORS LLC | $6.6M | 0.00% | , |
| CITADEL ADVISORS LLC | $5.6M | 0.00% | , |
| Bridgewater Associates, LP | $3.3M | 0.01% | , |
| Point72 Asset Management, L.P. | $1.8M | 0.00% | +521.1% |
| Point72 Asset Management, L.P. | $291K | 0.00% | , |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, BBIO
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
See more BBIO signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track BBIO in your watchlist and get notified the moment a new signal fires.
Track BBIO on Kresmion →